Study guide

3.3 HIPAA Privacy for Pharmacy

Minnesota MPJE Pharmacy Jurisprudence

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 About the Minnesota MPJE 1.2 NABP Competency Areas & Weights 1.3 How to Use This Guide & Study Strategy

2 Federal Controlled Substances Foundations

2.1 CSA Schedules I–V & MN Alignment 2.2 DEA Registration, Forms 222/106/41 & Security 2.3 Federal CS Prescription Rules (CII–CV) 2.4 Inventories, Recordkeeping & Theft/Loss

3 Federal Drug Regulation, Privacy & Supply Chain

3.1 FD&C Act, Legend vs OTC, Misbranding & Adulteration 3.2 OBRA '90, Medicaid DUR & Federal Counseling Floor 3.3 HIPAA Privacy for Pharmacy 3.4 DSCSA & Drug Supply Chain Integrity

4 MN Board, Licensure & Eligibility

4.1 Minnesota Board of Pharmacy Authority & Sources of Law 4.2 Pharmacist Licensure by Exam & Score Transfer 4.3 License Transfer (Reciprocity) & Background Checks 4.4 Interns, Preceptors & 1,600-Hour Experience

5 Renewal, CE, PIC & Discipline

5.1 License Renewal & 30-Hour Biennial CE 5.2 Pharmacist-in-Charge Duties 5.3 Discipline & Unprofessional Conduct 5.4 HPSP, Impaired Practitioners & Mandatory Reporting

6 Technicians, Interns & Supervision

6.1 Technician Registration, Training & CE 6.2 Supervision Ratios (Statute 151.102 & Rule 6800.3850) 6.3 Intern Scope, Delegation & Certification of Accuracy

7 Prescription Authority & Validity

7.1 Who May Prescribe in Minnesota 7.2 Prescription Content & Validity Requirements 7.3 Controlled Substance Prescribing (Chapter 152 + Federal) 7.4 Refills, Partial Fills & Quantity Limits

8 Advanced MN Pharmacist Practice

8.1 Collaborative Practice Agreements & Medication Therapy Management 8.2 Pharmacist Prescriptive Authority (Minn. Stat. 151.37) 8.3 Immunizations & Vaccine Administration 8.4 Drug Administration & Therapy Management

9 Counseling, DUR & Patient Safety

9.1 Patient Counseling Requirements (Rule 6800.0910) 9.2 Prospective Drug Utilization Review 9.3 Returning & Reusing Drugs (Rule 6800.2700)

10 MN PMP & Opioid Public-Health Laws

10.1 Minnesota PMP Overview, Reporting & Pharmacist Use 10.2 Naloxone Access, Steve’s Law & Opioid Antagonists 10.3 Legitimate Medical Purpose & Red Flags

11 Dispensing: Transfers, Labels & Substitution

11.1 Prescription Transfers Between Pharmacies 11.2 Labeling & Packaging of Dispensed Drugs 11.3 Generic Substitution & Product Selection 11.4 Emergency Dispensing, OTC/BTC & Pseudoephedrine

12 Pharmacy Operations & Facilities

12.1 Pharmacy Permits, Classifications & Inspections 12.2 Security, Delivery & Work Conditions 12.3 Operational Recordkeeping & Inventories 12.4 Central Fill, Centralized Processing & Automation

13 Compounding & Hazardous Drugs

13.1 Sterile, Nonsterile & Hazardous Compounding 13.2 Minnesota Compounding Rules & Beyond-Use Dates

14 Test-Day Strategy & Final Review

14.1 When Minnesota Law Is Stricter Than Federal Law 14.2 Test-Day Strategy & Common Traps

3.3 HIPAA Privacy for Pharmacy

Key Takeaways Explain This Topic AI

HIPAA Privacy and Security Rules protect individually identifiable health information held by covered entities and business associates; community pharmacies are covered health care providers when they transmit health information electronically in connection with standard transactions.

Protected Health Information (PHI) includes identifiable health data in any medium—electronic, paper, or oral—not only EHR screens.

Uses and disclosures for Treatment, Payment, and Health Care Operations (TPO) generally do not require written patient authorization; most non-TPO uses do.

The minimum necessary standard limits PHI to what is needed for the purpose, but it generally does not restrict disclosures for treatment among providers.

Breach notification for unsecured PHI requires individual notice without unreasonable delay and no later than 60 calendar days after discovery, with additional HHS and media duties for larger breaches.

Last updated: July 2026

3.3 HIPAA Privacy for Pharmacy

Minnesota MPJE focus: HIPAA is a federal privacy floor . Minnesota may add confidentiality duties for pharmacy records, PMP data, and Board investigations, but nearly every privacy question on the exam starts with HIPAA's PHI, TPO, minimum necessary, and breach rules. Apply the more protective applicable standard when both federal and state confidentiality rules apply.

Covered Entities, Business Associates, and Pharmacy Reality

The Health Insurance Portability and Accountability Act of 1996 (HIPAA) , strengthened by the HITECH Act and the Omnibus Rule , creates national standards for protecting health information. Covered entities include:

  • Health plans
  • Health care clearinghouses

Health care providers who transmit health information electronically in connection with standard transactions (claims, eligibility, etc.)

A typical Minnesota community or health-system pharmacy is a covered provider. Business associates are vendors that create, receive, maintain, or transmit PHI on the pharmacy's behalf (cloud hosts, e-prescribing networks, shredding services, certain analytics vendors). Pharmacies must execute Business Associate Agreements (BAAs) before sharing PHI with those vendors.

What Counts as PHI

Protected Health Information (PHI) is individually identifiable health information relating to a person's past, present, or future physical or mental health, the provision of health care, or payment for health care, held or transmitted by a covered entity or business associate. Medium does not matter:

  • Electronic (dispensing software, e-fax, email)
  • Paper (hard-copy Rx, printed profile, bag tag)
  • Oral (counseling conversations overheard at the counter)

Identifiers commonly linked to health data include name, street address, full ZIP in many contexts, dates (birth, fill), phone/email, SSN, medical record and prescription numbers, account numbers, device IDs, biometric identifiers, and full-face photos. De-identified data stripped of identifiers under HIPAA methods is not PHI.

  • Pharmacy PHI examples
  • Patient name + drug + directions on a vial label
  • Insurance BIN/PCN claim response tied to a beneficiary
  • Counseling notes about adherence or adverse effects
  • A technician calling a refill list within earshot of other customers (oral PHI risk)
  • TPO: When Authorization Is Not Required

Covered entities may use and disclose PHI without prior written patient authorization for Treatment, Payment, and Health Care Operations (TPO) :

TPO category Pharmacy examples

Treatment Dispensing, DUR, counseling, transferring a prescription, clarifying an order with a prescriber, coordinating with another pharmacy or clinic about therapy

Payment Submitting claims to PBMs/insurers, eligibility checks, billing inquiries, collection of copays tied to coverage

Health care operations Quality assurance, technician training with appropriately limited access, accreditation, fraud/abuse detection, legal defense related to operations

When you need written authorization

Uses outside TPO generally require a valid written authorization , including many marketing uses that sell patient lists, releases to employers for non-workers'-comp employment decisions, and releases to life insurers without another applicable permission. Authorizations must be specific, revocable in writing, and not combined with consent for treatment in coercive ways prohibited by the Privacy Rule.

Exam traps:

  • Sharing PHI with a marketing company for paid solicitation → authorization needed
  • Calling the prescriber about an interaction → treatment, no authorization needed

Giving a spouse the patient's entire profile without patient agreement or another permission → not automatically allowed just because of marriage; verify authority (personal representative, patient permission, or another HIPAA pathway)

Minimum Necessary Standard

The minimum necessary rule requires reasonable efforts to limit uses, disclosures, and requests of PHI to the least amount needed for the intended purpose.

Generally applies to: payment and many operations disclosures, non-treatment requests, workforce role-based access design.

Generally does NOT restrict: disclosures for treatment , disclosures to the individual , uses/disclosures made pursuant to a valid authorization that specifies the information, and certain required disclosures (for example, to HHS for compliance investigation).

Practical pharmacy design: cashiers need limited pick-up information; pharmacists need full clinical profiles for DUR; a PBM audit gets claim-relevant data, not the entire free-text counseling history without need.

Notice of Privacy Practices and Patient Rights

Patients receive a Notice of Privacy Practices (NPP) describing uses of PHI and rights to access, amend, request restrictions, and obtain accounting of certain disclosures. Pharmacies must make the NPP available and retain acknowledgment records when required. Patients may request confidential communications (for example, alternate phone numbers) that the pharmacy should accommodate when reasonable.

Safeguards (Privacy + Security in One Exam Breath)

Even when a use is allowed under TPO, the pharmacy must apply administrative, physical, and technical safeguards :

  • Role-based logins and unique user IDs
  • Screen privacy and clean desk habits at the counter
  • Secure destruction of labels and failed prints
  • Encrypted or otherwise secured electronic transmission when required by policy/rule
  • Training and sanctions for workforce snooping ("celebrity look-ups")

Workforce curiosity access is a classic impermissible use even if no data leaves the building.

Breach Notification Basics

A breach is generally an impermissible use or disclosure of unsecured PHI that compromises privacy or security, subject to risk-assessment exceptions (for example, low probability of compromise under the regulatory factors, or certain good-faith unintentional access within scope of authority).

Core timelines and duties (exam-level):

Notify affected individuals without unreasonable delay and no later than 60 calendar days after discovery of a breach of unsecured PHI

Notify the HHS Secretary (timing differs for breaches affecting 500 or more individuals versus smaller breaches reported annually)

  • For breaches affecting 500 or more individuals in a state/jurisdiction, notify prominent media as required
  • Business associates must notify the covered entity so the pharmacy can meet its duties

Unsecured PHI means PHI not rendered unusable/unreadable via technologies or methods specified by HHS (for example, proper encryption/destruction). Securely encrypted data may fall outside breach-notification duties if the encryption meets guidance.

  • Incident response sequence for exam vignettes
  • Contain (recover misdirected fax, lock accounts)
  • Investigate and risk-assess
  • Mitigate harm
  • Notify as required if a breach of unsecured PHI occurred
  • Document decisions and corrective actions
  • Minnesota Overlay Notes

HIPAA does not authorize ignoring Minnesota PMP confidentiality rules or Board record requirements.

Counseling under Rule 6800.0910 necessarily involves oral PHI—conduct it with reasonable privacy , not broadcast across the waiting area when avoidable.

Transfers, central fill, and cloud vendors require both HIPAA (BAA/TPO analysis) and pharmacy practice agreements.

Section Checkpoint

PHI = identifiable health data in any form.

TPO → usually no authorization; marketing/employer/life-insurer type asks usually need one.

Minimum necessary limits non-treatment uses; treatment disclosures are largely unrestricted by that rule.

Breach of unsecured PHI → individual notice ≤ 60 days from discovery, plus HHS/media when thresholds apply.